Martin Ward
6Patents
2h-index
5Co-inventors
40Inventor score
Filing activity: Mar 28, 2007 → Aug 6, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11401306B2 | HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereof | Chemistry; Metallurgy | 7 | Active |
| US8093459B2 | Modification of plant development and morphology | Emerging Cross-Sectional Technologies | 5 | Active |
| US11612652B2 | Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy | Chemistry; Metallurgy | 2 | Active |
| US11638753B2 | Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy | Chemistry; Metallurgy | 2 | Active |
| US9481890B2 | Modification of plant development and morphology | Emerging Cross-Sectional Technologies | 0 | Active |
| US8575423B2 | Modification of plant development and morphology | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.